| Name: | Efavirenz Related Compound C |
| Catalogue No. | VL1680005 |
| CAS No. | 391860-73-4 |
| Molecular Formula | C13H9ClF3N |
| Molecular Weight | 271.67 |
| Status | In-stock |
| IUPAC Name | 6-Chloro-2-cyclopropyl-4-(trifluoromethyl)-quinoline |
| Synonyms | Efavirenz Quinoline Impurity / Efavirenz IP Impurity F |
| Description | Efavirenz Related Compound C or Efavirenz Quinoline Impurity / Efavirenz IP Impurity F or (CAS No.391860-73-4) or 6-Chloro-2-cyclopropyl-4-(trifluoromethyl)-quinoline. Efavirenz is a non-nucleoside reverse transcriptase inhibitor (NNRTI) that shows inhibitory action against HIV-1. It is a benzoxazinone and orally active compound. |
| References | "Adkins, Julie C., and Stuart Noble. “Efavirenz.” Drugs, vol. 56, no. 6, 1998, pp. 1055–64, https://doi.org/10.2165/00003495-199856060-00014. Kenedi, Christopher A., and Harold W. Goforth. “A Systematic Review of the Psychiatric Side-Effects of Efavirenz.” AIDS and Behavior, vol. 15, no. 8, Apr. 2011, pp. 1803–18, https://doi.org/10.1007/s10461-011-9939-5. " |
